Astellas Pharma Inc.: Won’t Raise OSI Pharmaceuticals, Inc. Bid on FDA Move Alone

Reuters -- Astellas Pharma (4503.T), Japan's No.2 drugmaker, said on Monday it has no plan to lift its bid for OSI Pharmaceuticals (OSIP.O) despite U.S. regulators approving wider use of OSI's cancer pill Tarceva.